Clinical evaluation of RSA pacing in post-surgery patients

接受心脏手术的患者经常发现，在手术后的恢复期，他们的心脏难以为身体提供足够的血液。Ceryx已经开发出一种独特的起搏设备，能够在提高心脏性能的同时减少心脏的工作量，这可以帮助心脏康复。在这个项目中，Ceryx将在心脏手术后的患者身上试验其新技术。Ceryx将把他们的技术与现有的临时起搏设备连接起来，患者在手术中通常会安装这种设备。在Ceryx公司的技术驱动下，这种设备将向心脏输送治疗性起搏，直到患者准备好出院，通常是在大约一周后。在此期间，将监测患者心脏的功能和结构是否有所改善。患者的运动能力以及他们的症状和生活质量也将得到评估。如果试验成功，该项目将极大地加速Ceryx技术的发展，并可能在1-2年内推出一种用于心脏手术后康复患者的新疗法。

Patients who undergo cardiac surgery often find their hearts struggle to supply enough blood to the body during the recovery period post-surgery. Ceryx have developed a unique pacing device which is able to boost the performance of the heart while also reducing the workload on the heart, which can help the heart to heal. In this project, Ceryx will trial its new technology in patients following cardiac surgery.Ceryx will interface their technology to an existing temporary pacing device which patients are routinely fitted with during surgery. Driven by Ceryx's technology this device will then deliver the therapeutic pacing to the heart until the patient is ready to be discharged, usually after about a week. During this time the patient's heart will be monitored for improvements in function and structure. The patients' ability to exercise will also be assessed, along with their symptoms and quality of life.If the trial is successful, this project will have accelerated the development of Ceryx's technology considerably and it may be that a new therapy for patients recovering from cardiac surgery could be on the market in 1-2 years.